Tuesday, November 26th, 2019
11:50 Patients, Patents and Price: Can Life Science Innovation Survive the Politics of Affordable Health?
The incentive system in life sciences faces an existential challenge which could fundamentally change the way our businesses patent, publish, and innovate. The political pressure to lower costs of patient care and curb perceived abuses of the patent system have led to numerous calls to curtail patents, term extensions, and other protections – but, can we change the course of the discussion through positive action? This presentation will examine those challenges, propose steps we can take to demonstrate patient value, and invite discussion about how we can continue to deliver on our commitment to improving the lives of patients.
This session will:
· Provide a summary review of (proposed) legislative changes to US / EU pharmaceutical patent law;
· Examine voluntary steps companies can take to demonstrate commitment to core innovation and patient value;
· Encourage discussion and best practice sharing among participants.